Physician profile
Thomas Easterday
NPI 1386026862
$1,079.80
in general payments reported to CMS, 2019-2025
11 companies · $115 in 2025
The $115 reported for 2025 was less than what a typical Surgical Critical Care provider received nationally (typical 2025 total: $234).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $141 · 2020: $118 · 2021: $30.89 · 2022: $179 · 2023: $211 · 2024: $286 · 2025: $115.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $611.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $610.93 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zimmer Biomet Holdings, INC. | $490.23 | 2022-2025 | Advantagerib, Ribfix Blu Advantage, Ribfix Titan |
| La Jolla Pharmaceutical Company | $123.89 | 2019 | |
| Acell, INC. | $117.53 | 2020 | |
| Smith+Nephew, INC. | $116.39 | 2024 | Stravix Pl, Oasis, Oasis Micro |
| Baxter Healthcare | $64.05 | 2021-2022 | |
| Polynovo North America LLC | $43.90 | 2024 | Novosorb Btm |
| Atricure, INC. | $34.18 | 2024-2025 | Atricure Cryoice Cryosphere Cryoablation System |
| Haemonetics Corporation | $31.51 | 2025 | Teg6s Hemostasis System |
| Integra Lifesciences Corporation | $21.11 | 2023 | Integra, Integra Dermal Regeneration Template, Primatrix |
| Kci USA, INC. | $19.51 | 2023 | V.A.C. Veraflo, Prevena |
| Merck Sharp & Dohme LLC | $17.50 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Thomas Easterday listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.